Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Starting soon

Conditions studied: Rhabdomyosarcoma

In brief

The study seeks to delve into the firsthand experiences of patients diagnosed with rhabdomyosarcoma who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all rhabdomyosarcoma patients as well as those in under-represented demographic groups.

Key facts

Study ID

NCT06029465

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-10-01

Expected to finish

2026-10-01

Last updated by the study team

2023-09-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of rhabdomyosarcoma
• Considered reliable, able to understand, and willing to perform all study procedures
• Signed Written Informed Consent

You may not qualify if…

• Currently enrolled in, have completed or have discontinued from a clinical trial involving an investigational drug
• Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• Any serious and/or unstable pre-existing medical disorders

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.